-
2
-
-
0025281007
-
Treatment of uterine sarcomas
-
Echt G, Jepson J, Steel J, et al. Treatment of uterine sarcomas. Cancer. 1990; 66: 35-39.
-
(1990)
Cancer.
, vol.66
, pp. 35-39
-
-
Echt, G.1
Jepson, J.2
Steel, J.3
-
3
-
-
0024557084
-
Patterns of metastasis in uterine sarcoma. An autopsy study
-
Rose PG, Piver MS, Tsukada Y, Lau T,. Patterns of metastasis in uterine sarcoma. An autopsy study. Cancer. 1989; 63: 935-938.
-
(1989)
Cancer.
, vol.63
, pp. 935-938
-
-
Rose, P.G.1
Piver, M.S.2
Tsukada, Y.3
Lau, T.4
-
4
-
-
38549166650
-
Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths
-
Ueda SM, Kapp DS, Cheung MK, et al. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Am J Obstet Gynecol. 2008; 198: 218.e1-218.e6.
-
(2008)
Am J Obstet Gynecol.
, vol.198
-
-
Ueda, S.M.1
Kapp, D.S.2
Cheung, M.K.3
-
5
-
-
65349159791
-
Stage-specific outcomes of patients with uterine leiomyosarcoma: A comparison of the International Federation of Gynecology and Obstetrics and American Joint Committee on Cancer staging systems
-
Zivanovic O, Leitao MM, Iasonos A, et al. Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the International Federation of Gynecology and Obstetrics and American Joint Committee on Cancer staging systems. J Clin Oncol. 2009; 27: 2066-2072.
-
(2009)
J Clin Oncol.
, vol.27
, pp. 2066-2072
-
-
Zivanovic, O.1
Leitao, M.M.2
Iasonos, A.3
-
6
-
-
0141645574
-
Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus
-
Leitao MM, Sonoda Y, Brennan MF, Barakat RR, Chi DS,. Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus. Gynecol Oncol. 2003; 91: 209-212.
-
(2003)
Gynecol Oncol.
, vol.91
, pp. 209-212
-
-
Leitao, M.M.1
Sonoda, Y.2
Brennan, M.F.3
Barakat, R.R.4
Chi, D.S.5
-
7
-
-
0022006615
-
A randomized clinical trial of adjuvant Adriamycin in uterine sarcomas: A Gynecologic Oncology Group study
-
Omura GA, Blessing JA, Major F, et al. A randomized clinical trial of adjuvant Adriamycin in uterine sarcomas: a Gynecologic Oncology Group study. J Clin Oncol. 1985; 3: 1240-1245.
-
(1985)
J Clin Oncol.
, vol.3
, pp. 1240-1245
-
-
Omura, G.A.1
Blessing, J.A.2
Major, F.3
-
8
-
-
41849100978
-
European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages i and II: A European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group study (protocol 55874)
-
Reed NS, Mangioni C, Malmstrom H, et al. European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: a European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group study (protocol 55874). Eur J Cancer. 2008; 44: 808-818.
-
(2008)
Eur J Cancer.
, vol.44
, pp. 808-818
-
-
Reed, N.S.1
Mangioni, C.2
Malmstrom, H.3
-
10
-
-
45849107274
-
Prophylactic pelvic irradiation as part of primary therapy in uterine sarcomas
-
Sorbe B, Johansson B,. Prophylactic pelvic irradiation as part of primary therapy in uterine sarcomas. Int J Oncol. 2008; 32: 1111-1117.
-
(2008)
Int J Oncol.
, vol.32
, pp. 1111-1117
-
-
Sorbe, B.1
Johansson, B.2
-
11
-
-
0023931103
-
Treatment of uterine leiomyosarcoma
-
Berchuck A, Rubin SC, Hoskins WJ, Saigo PE, Pierce VK, Lewis JL Jr,. Treatment of uterine leiomyosarcoma. Obstet Gynecol. 1988; 71 (6 pt 1): 845-850.
-
(1988)
Obstet Gynecol.
, vol.71
, Issue.6 PART 1
, pp. 845-850
-
-
Berchuck, A.1
Rubin, S.C.2
Hoskins, W.J.3
Saigo, P.E.4
Pierce, V.K.5
Lewis Jr., J.L.6
-
12
-
-
70350008454
-
Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma
-
Raut CP, Nucci MR, Wang Q, et al. Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma. Eur J Cancer. 2009; 45: 2818-2824.
-
(2009)
Eur J Cancer.
, vol.45
, pp. 2818-2824
-
-
Raut, C.P.1
Nucci, M.R.2
Wang, Q.3
-
13
-
-
66549090700
-
FIGO staging for uterine sarcomas
-
Prat J,. FIGO staging for uterine sarcomas. Int J Gynaecol Obstet. 2009; 104: 177-178.
-
(2009)
Int J Gynaecol Obstet.
, vol.104
, pp. 177-178
-
-
Prat, J.1
-
14
-
-
68149162597
-
Prognostic factors in early stage leiomyosarcoma of the uterus
-
Pelmus M, Penault-Llorca F, Guillou L, et al. Prognostic factors in early stage leiomyosarcoma of the uterus. Int J Gynecol Cancer. 2009; 19: 385-390.
-
(2009)
Int J Gynecol Cancer.
, vol.19
, pp. 385-390
-
-
Pelmus, M.1
Penault-Llorca, F.2
Guillou, L.3
-
15
-
-
60349124586
-
Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients
-
Abeler VM, Royne O, Thoresen S, Danielsen HE, Nesland JM, Kristensen GB,. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology. 2009; 54: 355-364.
-
(2009)
Histopathology.
, vol.54
, pp. 355-364
-
-
Abeler, V.M.1
Royne, O.2
Thoresen, S.3
Danielsen, H.E.4
Nesland, J.M.5
Kristensen, G.B.6
-
16
-
-
0842332132
-
The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital
-
Dinh TA, Oliva EA, Fuller AF Jr, Lee H, Goodman A,. The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital. Gynecol Oncol. 2004; 92: 648-652.
-
(2004)
Gynecol Oncol.
, vol.92
, pp. 648-652
-
-
Dinh, T.A.1
Oliva, E.A.2
Fuller Jr., A.F.3
Lee, H.4
Goodman, A.5
-
17
-
-
0032771172
-
Leiomyosarcoma of the uterus: A clinicopathologic multicenter study of 71 cases
-
Mayerhofer K, Obermair A, Windbichler G, et al. Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol. 1999; 74: 196-201.
-
(1999)
Gynecol Oncol.
, vol.74
, pp. 196-201
-
-
Mayerhofer, K.1
Obermair, A.2
Windbichler, G.3
-
18
-
-
0023898196
-
The role of the pathologist in the management of soft tissue sarcomas
-
Hajdu SI, Shiu MH, Brennan MF,. The role of the pathologist in the management of soft tissue sarcomas. World J Surg. 1988; 12: 326-331.
-
(1988)
World J Surg.
, vol.12
, pp. 326-331
-
-
Hajdu, S.I.1
Shiu, M.H.2
Brennan, M.F.3
-
19
-
-
0028335176
-
Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases
-
Bell SW, Kempson RL, Hendrickson MR,. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol. 1994; 18: 535-558.
-
(1994)
Am J Surg Pathol.
, vol.18
, pp. 535-558
-
-
Bell, S.W.1
Kempson, R.L.2
Hendrickson, M.R.3
-
20
-
-
41549166181
-
Uterine mesenchymal tumors: A review of selected topics
-
Soslow RA,. Uterine mesenchymal tumors: a review of selected topics. Diagn Histopathol. 2008; 14: 175-188.
-
(2008)
Diagn Histopathol.
, vol.14
, pp. 175-188
-
-
Soslow, R.A.1
-
21
-
-
37348999883
-
Diagnostic criteria for uterine smooth muscle tumors: Leiomyoma variants associated with malignant behavior
-
Giuntoli RL second, Gostout BS, DiMarco CS, Metzinger DS, Keeney GL,. Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior. J Reprod Med. 2007; 52: 1001-1010.
-
(2007)
J Reprod Med.
, vol.52
, pp. 1001-1010
-
-
Giuntoli Second, R.L.1
Gostout, B.S.2
Dimarco, C.S.3
Metzinger, D.S.4
Keeney, G.L.5
-
22
-
-
44449135941
-
Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study
-
Hensley ML, Blessing JA, Degeest K, Abulafia O, Rose PG, Homesley HD,. Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study. Gynecol Oncol. 2008; 109: 323-328.
-
(2008)
Gynecol Oncol.
, vol.109
, pp. 323-328
-
-
Hensley, M.L.1
Blessing, J.A.2
Degeest, K.3
Abulafia, O.4
Rose, P.G.5
Homesley, H.D.6
-
23
-
-
44449096592
-
Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II trial
-
Hensley ML, Blessing JA, Mannel R, Rose PG,. Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial. Gynecol Oncol. 2008; 109: 329-334.
-
(2008)
Gynecol Oncol.
, vol.109
, pp. 329-334
-
-
Hensley, M.L.1
Blessing, J.A.2
Mannel, R.3
Rose, P.G.4
-
24
-
-
60449099927
-
Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study
-
Hensley ML, Ishill N, Soslow R, et al. Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: results of a prospective study. Gynecol Oncol. 2009; 112: 563-567.
-
(2009)
Gynecol Oncol.
, vol.112
, pp. 563-567
-
-
Hensley, M.L.1
Ishill, N.2
Soslow, R.3
-
25
-
-
0037096747
-
Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: Results of a phase II trial
-
Hensley ML, Maki R, Venkatraman E, et al. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol. 2002; 20: 2824-2831.
-
(2002)
J Clin Oncol.
, vol.20
, pp. 2824-2831
-
-
Hensley, M.L.1
Maki, R.2
Venkatraman, E.3
-
26
-
-
34447572873
-
Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: Results of Sarcoma Alliance for Research Through Collaboration study 002 [corrected]
-
Maki RG, Wathen JK, Patel SR, et al. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of Sarcoma Alliance for Research Through Collaboration study 002 [corrected]. J Clin Oncol. 2007; 25: 2755-2763.
-
(2007)
J Clin Oncol.
, vol.25
, pp. 2755-2763
-
-
Maki, R.G.1
Wathen, J.K.2
Patel, S.R.3
-
27
-
-
41649106685
-
How to build and interpret a nomogram for cancer prognosis
-
Iasonos A, Schrag D, Raj GV, Panageas KS,. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008; 26: 1364-1370.
-
(2008)
J Clin Oncol.
, vol.26
, pp. 1364-1370
-
-
Iasonos, A.1
Schrag, D.2
Raj, G.V.3
Panageas, K.S.4
-
28
-
-
0030069896
-
Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors
-
Harrell FE Jr, Lee KL, Mark DB,. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996; 15: 361-387.
-
(1996)
Stat Med.
, vol.15
, pp. 361-387
-
-
Harrell Jr., F.E.1
Lee, K.L.2
Mark, D.B.3
-
29
-
-
0037498554
-
Retrospective review of 208 patients with leiomyosarcoma of the uterus: Prognostic indicators, surgical management, and adjuvant therapy
-
Giuntoli RL, 2nd, Metzinger DS, DiMarco CS, et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol. 2003; 89: 460-469.
-
(2003)
Gynecol Oncol.
, vol.89
, pp. 460-469
-
-
Giuntoli II, R.L.1
Metzinger, D.S.2
Dimarco, C.S.3
-
30
-
-
39049114269
-
Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: Emphasis on impact of lymphadenectomy and oophorectomy
-
Kapp DS, Shin JY, Chan JK,. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy. Cancer. 2008; 112: 820-830.
-
(2008)
Cancer.
, vol.112
, pp. 820-830
-
-
Kapp, D.S.1
Shin, J.Y.2
Chan, J.K.3
-
31
-
-
27944450863
-
Concordance probability and discriminatory power in proportional hazards regression
-
Gonen M, Heller G,. Concordance probability and discriminatory power in proportional hazards regression. Biometrika. 2005; 92: 965-970.
-
(2005)
Biometrika.
, vol.92
, pp. 965-970
-
-
Gonen, M.1
Heller, G.2
-
32
-
-
33748464977
-
Are nomograms better than currently available stage groupings for bladder cancer?
-
Sternberg CN,. Are nomograms better than currently available stage groupings for bladder cancer? J Clin Oncol. 2006; 24: 3819-3820.
-
(2006)
J Clin Oncol.
, vol.24
, pp. 3819-3820
-
-
Sternberg, C.N.1
-
33
-
-
0037336502
-
Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: Preoperative application in prostate cancer
-
Kattan MW,. Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer. Curr Opin Urol. 2003; 13: 111-116.
-
(2003)
Curr Opin Urol.
, vol.13
, pp. 111-116
-
-
Kattan, M.W.1
-
34
-
-
38649125855
-
Individualized prediction of colon cancer recurrence using a nomogram
-
Weiser MR, Landmann RG, Kattan MW, et al. Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol. 2008; 26: 380-385.
-
(2008)
J Clin Oncol.
, vol.26
, pp. 380-385
-
-
Weiser, M.R.1
Landmann, R.G.2
Kattan, M.W.3
-
35
-
-
34548504813
-
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer
-
Walz J, Gallina A, Saad F, et al. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol. 2007; 25: 3576-3581.
-
(2007)
J Clin Oncol.
, vol.25
, pp. 3576-3581
-
-
Walz, J.1
Gallina, A.2
Saad, F.3
-
36
-
-
0036467991
-
Postoperative nomogram for 12-year sarcoma-specific death
-
Kattan MW, Leung DH, Brennan MF,. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002; 20: 791-796.
-
(2002)
J Clin Oncol.
, vol.20
, pp. 791-796
-
-
Kattan, M.W.1
Leung, D.H.2
Brennan, M.F.3
-
37
-
-
0347224331
-
Cancer and Leukemia Group B (CALGB) 90203: A randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease
-
Cancer and Leukemia Group B
-
Eastham JA, Kelly WK, Grossfeld GD, Small EJ,; Cancer and Leukemia Group B. Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease. Urology. 2003; 62 (suppl 1): 55-62.
-
(2003)
Urology.
, vol.62
, Issue.SUPPL. 1
, pp. 55-62
-
-
Eastham, J.A.1
Kelly, W.K.2
Grossfeld, G.D.3
Small, E.J.4
-
38
-
-
0032950295
-
Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer
-
Kattan MW, Wheeler TM, Scardino PT,. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol. 1999; 17: 1499-1507.
-
(1999)
J Clin Oncol.
, vol.17
, pp. 1499-1507
-
-
Kattan, M.W.1
Wheeler, T.M.2
Scardino, P.T.3
-
39
-
-
27244432751
-
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
-
Stephenson AJ, Scardino PT, Eastham JA, et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol. 2005; 23: 7005-7012.
-
(2005)
J Clin Oncol.
, vol.23
, pp. 7005-7012
-
-
Stephenson, A.J.1
Scardino, P.T.2
Eastham, J.A.3
-
40
-
-
0142008434
-
Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma
-
Kattan MW, Karpeh MS, Mazumdar M, Brennan MF,. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol. 2003; 21: 3647-3650.
-
(2003)
J Clin Oncol.
, vol.21
, pp. 3647-3650
-
-
Kattan, M.W.1
Karpeh, M.S.2
Mazumdar, M.3
Brennan, M.F.4
-
41
-
-
3242671534
-
Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas
-
Brennan MF, Kattan MW, Klimstra D, Conlon K,. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg. 2004; 240: 293-298.
-
(2004)
Ann Surg.
, vol.240
, pp. 293-298
-
-
Brennan, M.F.1
Kattan, M.W.2
Klimstra, D.3
Conlon, K.4
-
42
-
-
0035819891
-
Validation of the Gail et al model of breast cancer risk prediction and implications for chemoprevention
-
Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA,. Validation of the Gail et al model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst. 2001; 93: 358-366.
-
(2001)
J Natl Cancer Inst.
, vol.93
, pp. 358-366
-
-
Rockhill, B.1
Spiegelman, D.2
Byrne, C.3
Hunter, D.J.4
Colditz, G.A.5
-
43
-
-
4444252760
-
Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma
-
Leitao MM, Soslow RA, Nonaka D, et al. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer. 2004; 101: 1455-1462.
-
(2004)
Cancer.
, vol.101
, pp. 1455-1462
-
-
Leitao, M.M.1
Soslow, R.A.2
Nonaka, D.3
|